Overview
- Intel confirmed in its recent earnings disclosures that it will start risk production for internal products on 14A in the second half of 2027 and begin high-volume production in 2028.
- The company says 14A is already outpacing its 18A node on defect density and transistor performance, a technical claim it cites to justify the accelerated schedule.
- Q2 2026 results that supported the move include $16.1 billion in revenue, driven by a 59% year-over-year rise in Data Center and AI sales and stronger client pricing.
- Intel Foundry narrowed its operating loss to $2.1 billion in Q2 as yields, cycle times, and wafer starts improved across Intel 7, Intel 3 and 18A, but external 14A customer commitments have not been publicly disclosed.
- If execution holds, the shift could let Intel showcase the node on its own products first to attract partners, but the company still faces questions about outside customer adoption, timing versus TSMC, and the path to sustained foundry profitability.